Inventor

Douglas G. Batt

Inventor

Wilmington, DE, US

Overview

54→

Patents

1989–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 54 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds39%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%

A61KPreparations for medical, dental or toiletry purposes12%

C07CAcyclic or carbocyclic compounds9%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%

C07BGeneral methods of organic chemistry4%

C04BLime, magnesia2%

C07KPeptides1%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%

PatentTitleYear

11,053,197Carbazole derivatives2021 10,968,177Tricyclic sulfones as ROR2021 10,676,434Carbazole derivatives2020 10,435,415Substituted tetrahydrocarbazole and carbazole carboxamide compounds2019 10,435,369Tricyclic sulfones as ROR gamma modulators2019 10,266,491Carbazole derivatives2019 10,214,537Bicyclic heteroaryl amine compounds2019 10,106,559Substituted tetrahydrocarbazole and carbazole carboxamide compounds2018 10,000,480Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses2018 9,815,859'Tricyclic sulfones as RORÎ³ modulators'2017 9,714,234'Carbazole carboxamide compounds'2017 9,334,290'Substituted tetrahydrocarbazole and carbazole carboxamide compounds'2016 8,815,840'Carbazole and carboline kinase inhibitors'2014 8,759,390'Chromene modulators of chemokine receptor activity'2014 8,685,969'Carboline carboxamide compounds useful as kinase inhibitors'2014 8,507,559'Cyclohexenyl modulators of chemokine receptor activity'2013 8,362,065'Carbazole carboxamide compounds useful as kinase inhibitors'2013 8,084,620'Carbazole carboxamide compounds useful as kinase inhibitors'2011 7,829,571'Cyclic derivatives as modulators of chemokine receptor activity'2010 7,482,335'Cyclic derivatives as modulators of chemokine receptor activity'2009 7,479,496'Substituted spiro azabicyclics as modulators of chemokine receptor activity'2009 7,381,738'Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity'2008 7,378,409'Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity'2008 7,291,744'N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity'2007 7,288,563'Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity'2007 7,230,022'Substituted fused bicyclic amines as modulators of chemokine receptor activity'2007 7,163,937'Cyclic derivatives as modulators of chemokine receptor activity'2007 6,949,546'N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity'2005 6,919,356'N-substituted heterocyclic amines as modulators of chemokine receptor activity'2005 6,627,629'N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity'2003 6,214,834'Integrin inhibitor prodrugs'2001 6,114,328'Isoxazoline and isoxazole fibrogen receptor antagonists'2000 6,110,910'Carbocyclic heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents'2000 5,932,586'Prostaglandin synthase inhibitors'1999 5,874,441'Carbocyclic and hetertocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents'1999 5,849,736'Isoxazoline and isoxazole fibrinogen receptor antagonists'1998 5,760,028'Integrin receptor antagonists'1998 5,710,159'Integrin receptor antagonists'1998 5,707,844'Immunoassay reagents and methods for detecting brequinar and analogs'1998 5,639,759'Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents'1997 5,593,994'Prostaglandin synthase inhibitors'1997 5,578,609'2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents'1996 5,523,408'2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents'1996 5,428,040'Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents'1995 5,393,891'Immunoassay reagents and methods for detecting brequinar and analogs'1995 5,093,351'Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors'1992 5,049,570'Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity'1991 5,026,759'2-substituted-1-naphthols as 5-lipoxygenase inhibitors'1991 5,006,555'Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors'1991 4,985,435'2-substituted-1-naphthols as 5-lipoxygenase inhibitors'1991 4,985,442'2-substituted-1-naphthols as 5-lipoxygenase inhibitors'1991 4,906,636'2-Substituted-1-naphthols as 5-lipoxygenase inhibitors'1990 4,859,693'Antiinflammatory carbinoloimidazoles'1989 4,833,164'2-substituted-1-naphthols, pharmaceutical compositions of, and their use as 5-lipoxygenase inhibitors'1989

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1989–1991Patents assigned to DU PONT (6)· patent assignee history

1989–2021Based in Wilmington, DE, US· patent location history

1991–1998Patents assigned to DU PONT MERCK PHARMA (13)· patent assignee history

1999–2001Patents assigned to DU PONT PHARM CO (5)· patent assignee history

2005–2021Patents assigned to BRISTOL MYERS SQUIBB CO (28)· patent assignee history

2011–2014Patents assigned to BATT DOUGLAS G (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
BRISTOL MYERS SQUIBB CO	28	2005–2021
DU PONT MERCK PHARMA	13	1991–1998
BATT DOUGLAS Gself	6	2011–2014
DU PONT	6	1989–1991
DU PONT PHARM CO	5	1999–2001

Locations

Location	Patents	Span
Wilmington, Delaware, US	54	1989–2021